Patents by Inventor Farhat Syed

Farhat Syed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for IL-13 biomarkers
    Patent number: 7875427
    Abstract: Compositions and methods are provided for measuring and determining biomarkers for IL-13.
    Type: Grant
    Filed: September 29, 2006
    Date of Patent: January 25, 2011
    Assignee: Centocor, Inc.
    Inventors: Farhat Syed, Chong C. Huang, Katherine Li, Guihua Liu, Xiaozhou Shang, Li Li
  • Oxytocin Receptor Antagonists and Their Use for the Treatment of Pulmonary Related Diseases
    Publication number: 20100260675
    Abstract: Methods of treating disorders related to Oxytocin Receptor activity utilize OXYTOCIN RECEPTOR antagonists, such as antibodies, including specified portions or variants, polypeptides, polynucleotides, small molecule drugs, siRNA, shRNA, and DNAzymes. Disorders related to Oxytocin Receptor activity include inflammatory disorders, such as pulmonary disorders, for example, asthma, emphysema, and COPD.
    Type: Application
    Filed: December 8, 2005
    Publication date: October 14, 2010
    Inventors: Chong Huang, Farhat Syed, Li Li, Xilin Li, Gregory Arndt, Susan Pond
  • COMPOSITIONS AND METHODS FOR IL13 BIOMARKERS
    Publication number: 20070077585
    Abstract: Compositions and methods are provided for measuring and determining biomarkers for IL-13.
    Type: Application
    Filed: September 29, 2006
    Publication date: April 5, 2007
    Inventors: Farhat Syed, Chong Huang, Katherine Li, Guihua Liu, Xiaozhou Shang, Li Li
  • CNGH0011 polynucleotides, polypeptides, antibodies, and compositions, and methods of production and use
    Publication number: 20050260642
    Abstract: CNGH0011 polypeptides and nucleic acids encoding a variety of proteins have diagnostic, preventive, therapeutic, and other uses for a number of human and other animal disorders. Nucleic acid antagonist molecules (siRNA, shRNA, among others), expression vectors containing nucleic acid molecules, host cells into which the expression vectors have been introduced, fusion polypeptides, antigenic peptides and antibodies can be utilized to control the level of protein and regulate a variety of cellular processes in diagnostic, screening, and therapeutic methods.
    Type: Application
    Filed: March 31, 2005
    Publication date: November 24, 2005
    Inventors: Chong Huang, Farhat Syed, Li Li, Xilin Li, Gregory Arndt, Susan Pond